1. Current Principles in the Management of Drug-Resistant Epilepsy

   • Nathan A. Shlobin
   • Josemir W. Sander

   Current Opinion 20 May 2022 Pages: 555 - 568

2. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis

   • Per Soelberg Sorensen

   Review Article 19 May 2022 Pages: 569 - 589

   

3. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment

   • William Hong
   • Isabel Haviland
   • Heather E. Olson

   Review Article 28 May 2022 Pages: 591 - 604

   

4. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain

   • Madeline M. Corrao
   • Leigh Anne Nelson

   Review Article 30 May 2022 Pages: 605 - 616

5. Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation

   • Flaminia Coluzzi
   • Laura Rullo
   • Patrizia Romualdi

   Review Article Open access 26 May 2022 Pages: 617 - 632

   

6. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications

   • Yves Dauvilliers
   • Karel Šonka
   • Michael J. Thorpy

   Original Research Article Open access 30 May 2022 Pages: 633 - 647

   

7. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant

   • Lysbeth Floden
   • Stacie Hudgens
   • Jaskaran Singh

   Original Research Article Open access 20 April 2022 Pages: 649 - 658